Elizabeth O'Farrell

Ms. Elizabeth G.
O'Farrell is an Independent Director at SpyGlass Pharma, Inc., an Independent Director at Genmab A/S, an Independent Director at LENSAR, Inc., a Chairman at Geron Corp.
and a Chairman at PDL BioPharma, Inc. She is on the Board of Directors at SpyGlass Pharma, Inc., Karius, Inc., Genmab A/S and LENSAR, Inc. Ms. O'Farrell was previously employed as an Independent Director by Inhibikase Therapeutics, Inc., a Chief Procurement Officer by Eli Lilly & Co., a Chief Financial Office, SVP-Policy & Finance by Lilly USA LLC, a Chief Financial Officer & Executive Director by Eli Lilly Canada, Inc., an Accountant by OfficeMax Contract, Inc., an Auditor by Pricewaterhouse LLP, a Manager by Somerset Financial Services LLC, and an Auditor by Whipple & Co. She also served on the board at Y.M.C.A. Foundation of Greater Indianapolis, Washington Township Schools Foundation and Keep Indianapolis Beautiful, Inc. She received her undergraduate degree from Indiana University and an MBA from Indiana University.